SILX.F Stock Overview
A technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser enrichment technology in Australia, the United States, and the United Kingdom.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Silex Systems Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$3.55 |
| 52 Week High | AU$4.50 |
| 52 Week Low | AU$2.10 |
| Beta | 0.87 |
| 11 Month Change | 14.35% |
| 3 Month Change | 28.91% |
| 1 Year Change | 69.05% |
| 33 Year Change | 234.43% |
| 5 Year Change | 1,176.10% |
| Change since IPO | 293.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| SILX.F | US Machinery | US Market | |
|---|---|---|---|
| 7D | 2.5% | 7.0% | 5.1% |
| 1Y | 69.1% | 39.0% | 37.7% |
Return vs Industry: SILX.F exceeded the US Machinery industry which returned 39% over the past year.
Return vs Market: SILX.F exceeded the US Market which returned 37.7% over the past year.
Price Volatility
| SILX.F volatility | |
|---|---|
| SILX.F Average Weekly Movement | 10.1% |
| Machinery Industry Average Movement | 5.6% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: SILX.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: SILX.F's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | Michael Goldsworthy | www.silex.com.au |
Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser enrichment technology in Australia, the United States, and the United Kingdom. The company operates in three segments: Silex Systems, Translucent, and Silex USA. The company sells its cREO technology; and develops its laser-based enrichment technology for use in various applications comprising uranium production and enrichment for nuclear power; silicon enrichment for silicon quantum computing; and medical isotope enrichment for new cancer therapies.
Silex Systems Limited Fundamentals Summary
| SILX.F fundamental statistics | |
|---|---|
| Market cap | US$882.20m |
| Earnings (TTM) | -US$14.96m |
| Revenue (TTM) | US$7.37m |
119.7x
P/S Ratio-59.0x
P/E RatioIs SILX.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SILX.F income statement (TTM) | |
|---|---|
| Revenue | AU$11.20m |
| Cost of Revenue | AU$12.91m |
| Gross Profit | -AU$1.71m |
| Other Expenses | AU$21.02m |
| Earnings | -AU$22.73m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.096 |
| Gross Margin | -15.30% |
| Net Profit Margin | -203.02% |
| Debt/Equity Ratio | 0% |
How did SILX.F perform over the long term?
See historical performance and comparison